カテゴリ： MarketLine, 企業調査, 日本

Kyowa Hakko Kirin Co., Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15439
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：54
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Kyowa Hakko Kirin Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Kyowa Hakko Kirin Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Kyowa Hakko Kirin Co. Ltd (Kyowa Hakko or ‘the company’), a subsidiary of Kirin Holdings Company Limited, is a Japan-based provider of pharmaceuticals and bio-chemicals. It is primarily involved in the development and distribution of biotechnological products with major focus on oncology, nephrology and central nervous systems. The company offers its products under the brands: Pasetocin, Fortimicin, Sagamicin, Leunase, Adriacin, Hysron, Farmorubicin, Platosin, Navelbine, Depakene, Meditrans, Inovan, Coniel, Pre Dopa, Dobupum, Imagenil, Nauzelin, Glumin, Glumal, Navoban, Allelock, Celtect and Activacin. These products are used to treat hypertension, allergic reactions, anemia and behavioral disorders, to mention a few. Kyowa Hakko is headquartered in Tokyo, Japan.

Scope

- Detailed information on Kyowa Hakko Kirin Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kyowa Hakko Kirin Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Kyowa Hakko Kirin Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Kyowa Hakko Kirin Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kyowa Hakko Kirin Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Kyowa Hakko Kirin Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kyowa Hakko Kirin Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Kyowa Hakko Kirin Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Kyowa Hakko Kirin Co., Ltd.: Company Overview
Kyowa Hakko Kirin Co., Ltd.: Overview and Key Facts
Kyowa Hakko Kirin Co., Ltd.: Overview
Kyowa Hakko Kirin Co., Ltd.: Key Facts
Kyowa Hakko Kirin Co., Ltd.: Key Employees
Kyowa Hakko Kirin Co., Ltd.: Key Employee Biographies
Kyowa Hakko Kirin Co., Ltd.: Major Products and Services
Kyowa Hakko Kirin Co., Ltd.: Company History
Kyowa Hakko Kirin Co., Ltd.: Management Statement
Kyowa Hakko Kirin Co., Ltd.: Locations and Subsidiaries
Kyowa Hakko Kirin Co., Ltd.: Key Competitors
Kyowa Hakko Kirin Co., Ltd.: Company Analysis
Kyowa Hakko Kirin Co., Ltd.: Business Description
Kyowa Hakko Kirin Co., Ltd.: SWOT Analysis
Kyowa Hakko Kirin Co., Ltd.: SWOT Overview
Kyowa Hakko Kirin Co., Ltd.: Strengths
Kyowa Hakko Kirin Co., Ltd.: Weaknesses
Kyowa Hakko Kirin Co., Ltd.: Opportunities
Kyowa Hakko Kirin Co., Ltd.: Threats
Kyowa Hakko Kirin Co., Ltd.: Corporate Financial Deals Activity
Kyowa Hakko Kirin Co., Ltd.: Financial Deals Overview
Kyowa Hakko Kirin Co., Ltd.: Targets and Partners
Kyowa Hakko Kirin Co., Ltd.: Top Deals 2015 – 2019YTD*
Kyowa Hakko Kirin Co., Ltd.: Advisors
Kyowa Hakko Kirin Co., Ltd.: Top Legal Advisors
Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing
Kyowa Hakko Kirin Co., Ltd.: Partnership
Kyowa Hakko Kirin Co., Ltd.: Divestments
Kyowa Hakko Kirin Co., Ltd.: Recent Developments
Kyowa Hakko Kirin Co., Ltd.: News and Events Summary
Kyowa Hakko Kirin Co., Ltd.: Business Expansion
Kyowa Hakko Kirin Co., Ltd.: Corporate Governance
Kyowa Hakko Kirin Co., Ltd.: Regulatory and Legal Events
Kyowa Hakko Kirin Co., Ltd.: Research & Development
Kyowa Hakko Kirin Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Kyowa Hakko Kirin Co., Ltd.: Key Facts
Table 2: Kyowa Hakko Kirin Co., Ltd.: Key Employees
Table 3: Kyowa Hakko Kirin Co., Ltd.: Company History
Table 4: Kyowa Hakko Kirin Co., Ltd.: Locations and Subsidiaries
Table 5: Kyowa Hakko Kirin Co., Ltd.: Key Competitors
Table 6: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Kyowa Hakko Kirin Co., Ltd.: Targets and Partners
Table 9: Kyowa Hakko Kirin Co., Ltd.: Top Deals 2015 - 2019YTD*
Table 10: Kyowa Hakko Kirin Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 12: Kyowa Hakko Kirin Co., Ltd.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 13: Kyowa Hakko Kirin Co., Ltd.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 14: Kyowa Hakko Kirin Co., Ltd.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 15: Kyowa Hakko Kirin Co., Ltd.: Divestments by Geography (2015 - YTD*2019)
Table 16: Kyowa Hakko Kirin Co., Ltd.: News and Events Summary
Table 17: Kyowa Hakko Kirin Co., Ltd.: Business Expansion
Table 18: Kyowa Hakko Kirin Co., Ltd.: Corporate Governance
Table 19: Kyowa Hakko Kirin Co., Ltd.: Regulatory and Legal Events
Table 20: Kyowa Hakko Kirin Co., Ltd.: Research & Development
Table 21: Kyowa Hakko Kirin Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 4: Kyowa Hakko Kirin Co., Ltd.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 5: Kyowa Hakko Kirin Co., Ltd.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 6: Kyowa Hakko Kirin Co., Ltd.: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 7: Kyowa Hakko Kirin Co., Ltd.: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[Kyowa Hakko Kirin Co., Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • H3 Biomedicine Inc-製薬・医療分野：企業M&A・提携分析
    Summary H3 Biomedicine Inc (H3 Biomedicine), a subsidiary of Eisai Co Ltd is a biopharmaceutical company that offers therapies. The company concentrates on discovery and early development of novel, targeted anti-cancer compounds. Its products include small-molecule drugs that are developed by utiliz …
  • Suntory Holdings Ltd：企業の戦略・SWOT・財務情報
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • XOMA Corp (XOMA)：製薬・医療：M&Aディール及び事業提携情報
    Summary XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company that develops antibody-based therapeutics. Its lead product, gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include X358 …
  • Olmsted Medical Center：製薬・医療：M&Aディール及び事業提携情報
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes education, neurology, psychia …
  • Sagent Pharmaceuticals, Inc.：企業のM&A・事業提携・投資動向
    Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sagent Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Global Petroleum Ltd (GBP)：企業の財務・戦略的SWOT分析
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. It operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan de Nova …
  • DiaSorin S.p.A (DIA)-医療機器分野：企業M&A・提携分析
    Summary DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techni …
  • Grinners Catering (Australia) Pty Ltd
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Pharmacosmos AS：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Novacyt SA (ALNOV)：医療機器：M&Aディール及び事業提携情報
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Spherix Inc (SPEX)：企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • eTheRNA Immunotherapies NV：製薬・医療：M&Aディール及び事業提携情報
    Summary ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious disease …
  • GenMark Diagnostics Inc (GNMK)：企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Center for Applied Medical Research-製薬・医療分野：企業M&A・提携分析
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also provides support services suc …
  • Hospira Inc：医療機器：M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • Petrolympic Ltd (PCQ)：石油・ガス：M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • RATP Group：企業の戦略・SWOT・財務情報
    RATP Group - Strategy, SWOT and Corporate Finance Report Summary RATP Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TIE Kinetix N.V. (TIE)：企業の財務・戦略的SWOT分析
    TIE Kinetix N.V. (TIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Choice Spine LLC：製品パイプライン分析
    Summary Choice Spine LLC (Choice Spine) is a spinal implant company that develops, manufactures and markets surgeon focused systems. The company offers products which include cervical and thoracolumbar systems. Its cervical systems comprise plate systems, inter-body systems and fixation systems. Cho …
  • Brooks MacDonald Group PLC (BRK)：企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆